Public annual accounts

DOCTEURS HABRAN-PARZIBUT financials

Name: DOCTEURS HABRAN-PARZIBUT financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for DOCTEURS HABRAN-PARZIBUT, with comparable measures and links to available source documents.

Company overview

Registry number

0723836665

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

Latest movements for DOCTEURS HABRAN-PARZIBUT

2025 versus 2024

Operating line: €463,733
EBITDA: €460,891
Total assets: €1,463,633
Equity: €496,045

EBITDA margin +99.4% · Equity ratio +33.9%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€463,733	€460,891	€1,463,633	€496,045	-
202431 Dec 2024	€446,504	€443,954	€911,215	€729,308	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202531 Dec 2025

€463,733

€460,891

€1,463,633

€496,045

202431 Dec 2024

€446,504

€443,954

€911,215

€729,308